Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Gastrointest Surg. Nov 27, 2022; 14(11): 1219-1229
Published online Nov 27, 2022. doi: 10.4240/wjgs.v14.i11.1219
Figure 1
Figure 1 Patient flowchart. AC: Ampullary carcinoma; DC-II: Cancer of the second portion of the duodenum.
Figure 2
Figure 2 Survival curves of patients with cancer of the second portion of the duodenum (n = 27) and ampullary carcinoma (n = 80). A: Overall survival of patients with cancer of the second portion of the duodenum (DC-II) and ampullary cancer (AC); B: Relapse-free survival of patients with DC-II and AC.
Figure 3
Figure 3 The distribution of lymph node metastasis in patients with cancer of the second portion of the duodenum (n = 11) and ampullary carcinoma (n = 22). A: Metastasis to specific lymph nodes in 11 patients with DC-II; B: Metastasis to specific lymph nodes in 22 patients with AC. N-He: Hepatic lymph nodes; N-IP: Inferior pancreaticoduodenal nodes: N-Py: Pyloric lymph nodes; N-SM: Mesenteric nodes; N-SP: Superior pancreaticoduodenal nodes